KR20220051579A - Brain health improving formulation containing Pulsed Electric Field treated broccoli sprout extract - Google Patents
Brain health improving formulation containing Pulsed Electric Field treated broccoli sprout extract Download PDFInfo
- Publication number
- KR20220051579A KR20220051579A KR1020200135155A KR20200135155A KR20220051579A KR 20220051579 A KR20220051579 A KR 20220051579A KR 1020200135155 A KR1020200135155 A KR 1020200135155A KR 20200135155 A KR20200135155 A KR 20200135155A KR 20220051579 A KR20220051579 A KR 20220051579A
- Authority
- KR
- South Korea
- Prior art keywords
- days
- broccoli
- sprout
- extract
- broccoli sprout
- Prior art date
Links
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 title claims abstract description 123
- 235000017647 Brassica oleracea var italica Nutrition 0.000 title claims abstract description 123
- 240000003259 Brassica oleracea var. botrytis Species 0.000 title claims abstract description 120
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 230000036995 brain health Effects 0.000 title claims abstract description 30
- 230000005684 electric field Effects 0.000 title abstract description 16
- 238000009472 formulation Methods 0.000 title 1
- 230000006870 function Effects 0.000 claims abstract description 29
- 239000002858 neurotransmitter agent Substances 0.000 claims abstract description 15
- 208000036110 Neuroinflammatory disease Diseases 0.000 claims abstract description 13
- 230000003959 neuroinflammation Effects 0.000 claims abstract description 13
- 230000003956 synaptic plasticity Effects 0.000 claims abstract description 13
- 108010058651 thioglucosidase Proteins 0.000 claims abstract description 13
- 238000011084 recovery Methods 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 239000003795 chemical substances by application Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 22
- 239000012141 concentrate Substances 0.000 claims description 18
- 210000002569 neuron Anatomy 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000013535 sea water Substances 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 239000003112 inhibitor Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 230000030833 cell death Effects 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 235000017186 Celastrus paniculatus Nutrition 0.000 claims 1
- 235000018436 Embelia ribes Nutrition 0.000 claims 1
- 240000003098 Embelia ribes Species 0.000 claims 1
- 230000015654 memory Effects 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 15
- 230000002401 inhibitory effect Effects 0.000 abstract description 12
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 abstract description 10
- 230000016273 neuron death Effects 0.000 abstract description 6
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 abstract description 5
- 229960005559 sulforaphane Drugs 0.000 abstract description 5
- 235000015487 sulforaphane Nutrition 0.000 abstract description 5
- 230000001629 suppression Effects 0.000 abstract 2
- 238000011156 evaluation Methods 0.000 description 44
- 238000002474 experimental method Methods 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 10
- 238000001262 western blot Methods 0.000 description 7
- 206010012289 Dementia Diseases 0.000 description 6
- 229920001353 Dextrin Polymers 0.000 description 6
- 239000004375 Dextrin Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 235000019425 dextrin Nutrition 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000010336 energy treatment Methods 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 102000003952 Caspase 3 Human genes 0.000 description 4
- 108090000397 Caspase 3 Proteins 0.000 description 4
- 101710179684 Poly [ADP-ribose] polymerase Proteins 0.000 description 4
- 102100023712 Poly [ADP-ribose] polymerase 1 Human genes 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000012440 Acetylcholinesterase Human genes 0.000 description 3
- 108010022752 Acetylcholinesterase Proteins 0.000 description 3
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 3
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 3
- 244000308180 Brassica oleracea var. italica Species 0.000 description 3
- 229940022698 acetylcholinesterase Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000006993 memory improvement Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 102000003945 NF-kappa B Human genes 0.000 description 2
- 108010057466 NF-kappa B Proteins 0.000 description 2
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 2
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 description 2
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 108700000707 bcl-2-Associated X Proteins 0.000 description 2
- 102000055102 bcl-2-Associated X Human genes 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- RUQCCAGSFPUGSZ-OBWQKADXSA-N Glucoraphanin Natural products C[S@](=O)CCCCC(=NS(=O)(=O)O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RUQCCAGSFPUGSZ-OBWQKADXSA-N 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- GMMLNKINDDUDCF-JRWRFYLSSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1e)-5-[(r)-methylsulfinyl]-n-sulfooxypentanimidothioate Chemical compound C[S@@](=O)CCCC\C(=N/OS(O)(=O)=O)S[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GMMLNKINDDUDCF-JRWRFYLSSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010299 mechanically pulverizing process Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000009223 neuronal apoptosis Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000030648 nucleus localization Effects 0.000 description 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Abstract
Description
본 발명은 펄스전기장으로 처리한 브로콜리 새싹 추출물을 함유하는 두뇌건강기능 개선제 조성물 즉, 브로콜리새싹 추출물을 함유하는 두뇌 건강기능 개선제 조성물에 관한 것이며, 특히 기억력 개선에 도움이 되며, 신경세포 사멸 억제효과 및 신경염증 저해 효과가 우수하고, 신경전달물질 및 시냅스 가소성 회복에 도움이 되는 브로콜리새싹 추출물을 함유하는 두뇌 건강기능 개선제 조성물에 관한 것이다.The present invention relates to a brain health function improving composition containing a broccoli sprout extract treated with a pulsed electric field, that is, a brain health function improving agent composition containing a broccoli sprout extract, particularly helpful in improving memory, inhibiting neuronal cell death, and It is excellent in neuroinflammation inhibitory effect, and relates to a brain health function improving composition containing a broccoli sprout extract that helps to restore neurotransmitters and synaptic plasticity.
인간의 기억력은 뇌의 신경세포의 작용에 의하여 발휘되는 것이며, 뇌 신경세포는 다양한 신경전달 물질이 세포 사이의 간극인 시냅스를 통하여 전달되는 과정을 통하여 기억을 형성하고 또한 저장하게 된다.Human memory is exerted by the action of neurons in the brain, and brain neurons form and store memories through the process in which various neurotransmitters are transmitted through synapses, which are gaps between cells.
인간의 기억력을 증진시키기 위하여 다양한 연구가 수행되고 있으며, 예를들어, 하기 특허문헌 1은 청피경옥고를 유효성분으로 포함하는 신경세포보호 및 기억력개선효과를 갖는 약학 조성물 및 청피경옥고를 함유하는 기능성식품을 개시하고 있다. Various studies are being carried out to improve human memory, for example,
한편, 기억력 개선을 위하여는 기억력에 관여하는 신경세포의 사멸을 효과적으로 억제함과 동시에 기억력을 저하시킬 수 있는 신경염증을 저해시키고, 또한 기억력과 직접적으로 연관되는 신경전달물질 및 시냅스 가소성을 회복시켜야만 한다.On the other hand, in order to improve memory, it is necessary to effectively inhibit the death of nerve cells involved in memory, inhibit neuroinflammation that can lower memory, and also to restore neurotransmitters and synaptic plasticity directly related to memory. .
따라서, 기억력 개선의 효과를 향상시키기 위하여 기억력에 관여하는 신경세포의 사멸을 효과적으로 억제함과 동시에 기억력을 저하시킬 수 있는 신경염증을 저해시키고, 또한 기억력과 직접적으로 연관되는 신경전달물질 및 시냅스 가소성을 회복시킬 수 있는 조성물의 개발이 절실히 요구되는 실정이다.Therefore, in order to improve the effect of memory improvement, it effectively inhibits the death of nerve cells involved in memory and at the same time inhibits neuroinflammation that can decrease memory, and also improves the neurotransmitter and synaptic plasticity directly related to memory. There is an urgent need for the development of a recovery composition.
이에 본 발명에서는 상기 문제점을 해결하고자 브로콜리새싹 추출물 및 제주 용암해수;를 포함하는 조성물을 이용하여 기억력에 관여하는 신경세포의 사멸을 효과적으로 억제함과 동시에 기억력을 저하시킬 수 있는 신경염증을 저해시키고, 또한 기억력과 직접적으로 연관되는 신경전달물질 및 시냅스 가소성을 회복시킴으로써 기억력을 현저하게 개선시킬 수 있음을 발견하였고, 본 발명은 이에 기초하여 완성되었다.Therefore, in the present invention, in order to solve the above problems, a composition comprising a broccoli sprout extract and Jeju lava seawater is used to effectively inhibit the death of nerve cells involved in memory and at the same time inhibit neuroinflammation that can decrease memory, In addition, it was discovered that memory can be remarkably improved by restoring neurotransmitters and synaptic plasticity directly related to memory, and the present invention has been completed based on this.
본 발명의 일 구현예에 따른 두뇌건강기능 개선제 조성물은 용암해수로 키운브로콜리새싹 추출물을 포함한다.The brain health function improving agent composition according to an embodiment of the present invention includes an extract of broccoli sprouts grown with lava seawater.
본 발명의 일 구현예에 따른 두뇌건강기능 개선제 조성물에 있어서, 상기 브로콜리새싹 추출물은 브로콜리 새싹에 펄스에너지를 가하여 처리하는 단계(S100); 펄스에너지 처리된 상기 브로콜리 새싹을 착즙하여 새싹착즙액을 준비하는 단계(S200); 상기 새싹착즙액에 미로시나아제(myrosinase)를 혼합하고 반응시킨 후 발효주정으로 추출하여 새싹 발효주정 추출액을 준비하는 단계(S300); 상기 새싹 발효주정 추출액을 교반하고, 교반된 브로콜리 새싹 발효주정 추출액을 감압 농축시켜 브로콜리새싹 농축액을 준비하는 단계(S400); 상기 브로콜리새싹 농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하는 단계(S500); 및 상기 브로콜리새싹 건조물을 분쇄하여 분말로 만드는 단계(S600);를 통하여 제조된다.In the brain health function improving agent composition according to an embodiment of the present invention, the broccoli sprout extract is processed by applying pulse energy to the broccoli sprout (S100); Preparing a sprout juice by squeezing the broccoli sprouts treated with pulse energy (S200); Preparing the sprout fermented alcohol extract by mixing and reacting myrosinase with the sprout juice and extracting it with fermented alcohol (S300); preparing a broccoli sprout concentrate by stirring the sprout fermented alcohol extract and concentrating the stirred broccoli sprout fermented alcohol extract under reduced pressure (S400); Preparing the broccoli sprout extract by drying the broccoli sprout concentrate (S500); and grinding the dried broccoli sprouts into powder (S600).
본 발명의 일 구현예에 따른 두뇌건강기능 개선제 조성물에 있어서, 상기 조성물은 기억력 개선제인 것을 특징으로 한다.In the brain health function improving agent composition according to an embodiment of the present invention, the composition is characterized in that it is a memory improving agent.
본 발명의 일 구현예에 따른 두뇌건강기능 개선제 조성물에 있어서, 상기 조성물은 신경세포 사멸 억제제인 것을 특징으로 한다.In the brain health function improving agent composition according to an embodiment of the present invention, the composition is characterized in that it is a neuronal cell death inhibitor.
본 발명의 일 구현예에 따른 두뇌건강기능 개선제 조성물에 있어서, 상기 조성물은 신경염증 저해제인 것을 특징으로 한다.In the brain health function improving agent composition according to an embodiment of the present invention, the composition is characterized in that it is a neuroinflammation inhibitor.
본 발명의 일 구현예에 따른 두뇌건강기능 개선제 조성물에 있어서, 상기 조성물은 신경전달물질 및 시냅스 가소성 회복제인 것을 특징으로 한다.In the brain health function improving agent composition according to an embodiment of the present invention, the composition is characterized in that the composition is a neurotransmitter and a synaptic plasticity recovery agent.
본 발명에 따른 두뇌 건강기능 개선제 조성물은 펄스전기장 처리된 브로콜리새싹 추출물을 함유함으로써, 특히 기억력 개선에 도움이 되며, 신경세포 사멸 억제효과 및 신경염증 저해 효과가 우수하고, 신경전달물질 및 시냅스 가소성 회복에 도움이 되는 우수한 효과를 발휘한다.Brain health function improving composition according to the present invention contains a pulsed electric field-treated broccoli sprout extract, which is particularly helpful in improving memory, has excellent neuronal apoptosis inhibitory effect and neuroinflammation inhibitory effect, neurotransmitter and synaptic plasticity recovery It has an excellent effect conducive to
도 1에는 본 발명에 따라 제조된 브로콜리 새싹 추출물의 성분프로파일 그래프가 도시되어 있다.
도 2에는 상기 과정을 통하여 제조된 브로콜리 새싹 추출물의 주요성분인 설포라판(sulforaphane) 및 글루코라파닌(glucoraphanine)의 기준 및 시험방법 밸리데이션 값이 도시되어 있다.
도 3에는 상기 과정을 통하여 제조된 브로콜리 새싹 추출물의 주요성분 함량분석결과가 도시되어 있다.
도 4 내지 도 6에는 상기 과정을 통하여 제조된 브로콜리 새싹 추출물의 중금속 및 미생물시험 성적서가 도시되어 있다.1 is a graph showing the component profile of the broccoli sprout extract prepared according to the present invention.
2 shows the standards and test method validation values of sulforaphane and glucoraphanine, which are major components of the broccoli sprout extract prepared through the above process.
3 shows the results of analysis of the main component content of the broccoli sprout extract prepared through the above process.
4 to 6 show the heavy metal and microorganism test report of the broccoli sprout extract prepared through the above process.
본 발명을 좀 더 구체적으로 설명하기 전에, 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정되어서는 아니되며, 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 명세서에 기재된 실시 예의 구성은 본 발명의 바람직한 하나의 예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형 예들이 있을 수 있음을 이해하여야 한다.Before describing the present invention in more detail, the terms or words used in the present specification and claims should not be limited to their ordinary or dictionary meanings, and the concept of terms should be properly explained in order to best describe the invention. It should be interpreted as meaning and concept consistent with the technical idea of the present invention based on the principle that it can be defined in Therefore, the configuration of the embodiments described in the present specification is only one preferred example of the present invention, and does not represent all the technical spirit of the present invention, so various equivalents and modifications that can be substituted for them at the time of the present application It should be understood that there may be
이하, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 본 발명을 용이하게 실시할 수 있도록, 본 발명의 바람직한 실시 예들을 상세히 설명한다.Hereinafter, preferred embodiments of the present invention will be described in detail so that those of ordinary skill in the art can easily practice the present invention.
본 발명의 일 구현예에 따른 두뇌 건강기능개선제 조성물은 용암해수로 키운 브로콜리새싹 추출물을 포함한다.The brain health function improving agent composition according to an embodiment of the present invention includes an extract of broccoli sprouts grown in lava seawater.
본 발명의 일 구현예에 따른 두뇌 건강기능개선제 조성물은 다양한 의약용 담체와 혼합하여 정제(tablet) 형태로 가공하거나, 이를 의약용 캡슐에 담아 섭취하는 것이 가능하며, 병에 액상으로 담은 상태로 일정량씩 섭취하는 것 또한 가능하다.The brain health function improving agent composition according to an embodiment of the present invention can be mixed with various pharmaceutical carriers and processed into a tablet form, or it can be ingested in a pharmaceutical capsule, and a certain amount in a liquid state in a bottle It is also possible to take each.
한편, 본 발명의 일 구현예에 따른 두뇌 건강기능개선제 조성물을 다양한 식품에 첨가하여 식품으로 다양한 음식과 함께 섭취하는 것도 가능하다.On the other hand, it is also possible to ingest the brain health function improving agent composition according to an embodiment of the present invention as a food by adding it to various foods.
본 발명자는 용암해수로 키운 브로콜리새싹 추출물을 포함하는 조성물을 이용하여 기억력에 관여하는 신경세포의 사멸을 효과적으로 억제함과 동시에 기억력을 저하시킬 수 있는 신경염증을 저해시키고, 또한 기억력과 직접적으로 연관되는 신경전달물질 및 시냅스 가소성을 회복시킴으로써 기억력을 현저하게 개선시킬 수 있음을 발견하였으며, 이를 검증할 수 있는 다양한 실험을 수행하였다.The present inventors use a composition comprising a broccoli sprout extract grown with lava seawater to effectively inhibit the death of nerve cells involved in memory and at the same time inhibit neuroinflammation, which can decrease memory, and also directly related to memory. It was discovered that memory can be remarkably improved by restoring neurotransmitters and synaptic plasticity, and various experiments were conducted to verify this.
특히, 본 발명의 두뇌 건강기능개선제 조성물을 제조하기 위하여 본 발명자는 제주 용암해수를 이용하여 브로콜리 새싹을 키우는 방법을 사용하였으며, 일반 적인 정제수를 사용하는 경우에 비하여 제주 용암해수를 사용할 경우 본 발명 조성물의 기억력 개선 효과 등이 더욱 우수해지는 것을 확인하였다.In particular, in order to prepare the brain health function improving composition of the present invention, the present inventors used a method of growing broccoli sprouts using Jeju lava seawater. It was confirmed that the memory improvement effect of
또한, 본 발명에서는 브로콜리새싹 추출물을 하기의 방법을 추출하여 사용함으로써 기억력 개선의 효과를 향상시킬 수 있는 유효성분을 매우 효율적으로 추출할 수 있음을 발견하였다.In addition, in the present invention, it was found that active ingredients that can improve the effect of memory improvement can be extracted very efficiently by extracting and using the broccoli sprout extract as follows.
본 발명에 사용되는 브로콜리새싹 추출물은 다음과 같은 과정을 통하여 수행된다.The broccoli sprout extract used in the present invention is carried out through the following process.
즉, 상기 브로콜리새싹 추출물은 브로콜리 새싹에 펄스에너지를 가하여 처리하는 단계(S100); 펄스에너지 처리된 상기 브로콜리 새싹을 착즙하여 새싹착즙액을 준비하는 단계(S200); 상기 새싹착즙액에 미로시나아제(myrosinase)를 혼합하고 반응시킨 후 발효주정으로 추출하여 새싹 발효주정 추출액을 준비하는 단계(S300); 상기 새싹 발효주정 추출액을 교반하고, 교반된 브로콜리 새싹 발효주정 추출액을 감압 농축시켜 브로콜리새싹 농축액을 준비하는 단계(S400); 상기 브로콜리새싹 농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하는 단계(S500); 및 상기 브로콜리새싹 추출건조물을 분쇄하여 분말로 만드는 단계(S600);를 통하여 제조된다.That is, the broccoli sprout extract is processed by applying pulse energy to the broccoli sprout (S100); Preparing a sprout juice by squeezing the broccoli sprouts treated with pulse energy (S200); Preparing the sprout fermented alcohol extract by mixing and reacting myrosinase with the sprout juice and extracting it with fermented alcohol (S300); preparing a broccoli sprout concentrate by stirring the sprout fermented alcohol extract and concentrating the stirred broccoli sprout fermented alcohol extract under reduced pressure (S400); Preparing the broccoli sprout extract by drying the broccoli sprout concentrate (S500); and grinding the dried broccoli sprout extract into a powder (S600).
상기 브로콜리 새싹에 펄스에너지를 가하여 처리하는 단계(S100);는 펄스전기장 (Pulsed electric field, PEF)을 인가하는 과정이며, 예를 들어 (주)비케이바이오사의 펄스전기장(PEF)를 이용하여 상기 브로콜리 새싹의 세포막을 파괴하는 과정이다.The step (S100) of processing by applying pulse energy to the broccoli sprout is a process of applying a pulsed electric field (PEF), for example, the broccoli using a pulsed electric field (PEF) of BK Bio Inc. It is a process that destroys the cell membrane of the sprout.
상기 단계(S100);는 예를 들어, (주)비케이바이오사의 펄스전기장(PEF)를 작동시켜서 나오는 에너지를 브로콜리 새싹에 약 1분 내지 1시간 동안 인가하는 과정을 통하여 수행된다.The step (S100); is, for example, by operating a pulse electric field (PEF) of BK Bio Co., Ltd. is performed through the process of applying the energy to the broccoli sprout for about 1 minute to 1 hour.
상기 단계(S100)는 경우에 따라서는 브로콜리 새싹을 분쇄하는 과정으로 대체되는 것이 가능하다.In some cases, the step (S100) may be replaced by the process of crushing broccoli sprouts.
다음으로, 펄스에너지 처리된 상기 브로콜리 새싹을 착즙하여 새싹착즙액을 준비하는 단계(S200)를 수행하며, 이러한 과정을 통하여 브로콜리 새싹 추출물의 추출 효율을 더욱 증가시키는 것이 가능하다.Next, a step (S200) of preparing a sprout juice by squeezing the broccoli sprout treated with pulse energy is performed, and through this process, it is possible to further increase the extraction efficiency of the broccoli sprout extract.
다음으로, 상기 새싹착즙액에 미로시나아제(myrosinase)를 혼합하고 반응시킨 후 발효주정으로 추출하여 새싹 발효주정 추출액을 준비하는 단계(S300);를 수행한다.Next, a step (S300) of preparing the sprout fermented alcohol extract by mixing and reacting myrosinase with the sprout juice and extracting it with fermented alcohol (S300) is performed.
미로시나아제는 30 내지 40℃의 온도에서 10분 내지 10시간 반응시키는 것이 가능하다.Myrosinase can be reacted at a temperature of 30 to 40° C. for 10 minutes to 10 hours.
다음으로, 상기 새싹 발효주정 추출액을 교반하고, 브로콜리 새싹 발효주정 추출액을 감압 농축시켜 브로콜리새싹 농축액을 준비하는 단계(S400)를 수행한다.Next, the step (S400) of preparing the broccoli sprout concentrate by stirring the sprout fermented alcohol extract and concentrating the broccoli sprout fermented alcohol extract under reduced pressure is performed.
상기 교반과정은 20 내지 50℃의 온도로 약 3시간 동안 수행하는 것이 가능하다.The stirring process may be performed at a temperature of 20 to 50° C. for about 3 hours.
브로콜리 새싹 발효주정 추출과정은 약 10분 내지 12시간 동안 수행되는 것이 가능하다.The broccoli sprout fermented alcohol extraction process can be performed for about 10 minutes to 12 hours.
상기 감압 농축은 약 40℃의 온도에서 수행하는 것이 가능하다.The reduced pressure concentration may be performed at a temperature of about 40°C.
다음으로, 상기 브로콜리새싹 추출농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하는 단계(S500);를 수행한다.Next, the broccoli sprout extract concentrate is dried to prepare a dried broccoli sprout extract (S500); is performed.
마지막으로, 상기 브로콜리새싹 추출건조물을 분쇄하여 분말로 만드는 단계(S600);를 수행하며, 약 60메쉬로 여과된 분말을 제조하는 것이 가능하다.Finally, pulverizing the dried broccoli sprout extract to make a powder (S600); is performed, and it is possible to prepare a powder filtered with about 60 mesh.
이러한 과정을 통하여 제조된 브로콜리새싹 추출물은 약 3중량%의 높은 수율을 갖게 된다.The broccoli sprout extract prepared through this process has a high yield of about 3% by weight.
도 1에는 이러한 과정을 통하여 제조된 브로콜리 새싹 추출물의 성분프로파일 그래프가 도시되어 있다.1 shows a graph of the component profile of the broccoli sprout extract prepared through this process.
성분분석은 (주)비케이바이오의 Q-Orbitrap Mass Spectrometry로 수행하였으며, 각 추출물의 모든 피크에 대한 규명(identification)을 실시하였다.Component analysis was performed by Q-Orbitrap Mass Spectrometry of BK Bio Co., Ltd., and all peaks of each extract were identified.
도 2에는 상기 과정을 통하여 제조된 브로콜리 새싹 추출물의 주요성분인 설포라판(sulforaphane) 및 글루코라파닌(glucoraphanine)의 기준 및 시험방법 밸리데이션 값이 도시되어 있다.2 shows the standards and test method validation values of sulforaphane and glucoraphanine, which are major components of the broccoli sprout extract prepared through the above process.
도 3에는 상기 과정을 통하여 제조된 브로콜리 새싹 추출물의 주요성분 함량분석결과가 도시되어 있다.Figure 3 shows the main component content analysis result of the broccoli sprout extract prepared through the above process.
도 4 내지 도 6에는 상기 과정을 통하여 제조된 브로콜리 새싹 추출물의 중금속 및 미생물시험 성적서가 도시되어 있다.4 to 6 show the heavy metal and microorganism test report of the broccoli sprout extract prepared through the above process.
한편, 본 발명에 따른 두뇌 건강기능개선제 조성물은 식품으로 활용될 수 있음과 동시에 하기 효과를 발휘하는 의약으로 사용되는 것이 가능하다.On the other hand, the brain health function improving agent composition according to the present invention can be used as a food and at the same time as a medicine that exhibits the following effects.
즉, 본 발명에 따른 두뇌 건강기능개선제 조성물은 기억력 개선제로 사용될 수 있다.That is, the brain health function improving agent composition according to the present invention can be used as a memory improving agent.
또한, 본 발명에 따른 두뇌 건강기능개선제 조성물은 신경세포 사멸 억제제로 사용될 수 있다.In addition, the brain health function improving agent composition according to the present invention can be used as a nerve cell death inhibitor.
또한, 본 발명에 따른 두뇌 건강기능개선제 조성물은 신경염증 저해제로 사용될 수 있다.In addition, the brain health function improving agent composition according to the present invention can be used as a neuroinflammation inhibitor.
또한, 본 발명에 따른 두뇌 건강기능개선제 조성물은 신경전달물질 및 시냅스 가소성 회복제로 사용될 수 있다.In addition, the brain health function improving agent composition according to the present invention can be used as a neurotransmitter and synaptic plasticity recovery agent.
이하, 본 발명의 실시예에 따른 다양한 효과를 확인하기 위하여 수행된 실험에 대하여 설명한다.Hereinafter, experiments performed to confirm various effects according to an embodiment of the present invention will be described.
[제조예 1] - 브로콜리새싹 추출물 제조[Preparation Example 1] - Preparation of broccoli sprout extract
제주용암해수로 키운 브로콜리 새싹 50㎏에 (주)비케이바이오사의 펄스전기장(PEF)을 이용하여 약 1분간 펄스에너지를 가해줌으로써 브로콜리 새싹의 세포를 파괴하였다. 그 후, 이와 같이 펄스에너지 처리로 세포가 파괴된 브로콜리 새싹에 미로시나아제(myrosinase) 25g을 혼합하고 약 37℃의 온도로 약 2시간동안 반응시켜 설포라판이 강화된 브로콜리새싹 발효주정으로 추출하였다. 그 후, 이와 같이 추출된 브로콜리새싹 발효주정 추출액을 약 3시간 동안 교반하였으며, 다음으로, 교반된 브로콜리새싹 발효주정 추출액을 약 40℃의 온도에서 감압 농축시켜 브로콜리새싹 농축액을 준비하였다. 다음으로, 상기 브로콜리새싹 농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하였고, 마지막으로, 상기 브로콜리새싹 건조물을 분쇄하여 약 60메쉬로 여과된 분말을 제조하였다.The cells of broccoli sprouts were destroyed by applying pulse energy to 50 kg of broccoli sprouts grown in Jeju lava seawater for about 1 minute using a pulse electric field (PEF) from BK Bio. Thereafter, 25 g of myrosinase was mixed with the broccoli sprouts, whose cells were destroyed by the pulse energy treatment, and reacted at a temperature of about 37° C. for about 2 hours, followed by extraction with sulforaphane-enriched broccoli sprout fermented alcohol. Then, the broccoli sprout fermented alcohol extract thus extracted was stirred for about 3 hours, and then, the stirred broccoli sprout fermented alcohol extract was concentrated under reduced pressure at a temperature of about 40° C. to prepare a broccoli sprout concentrate. Next, the broccoli sprout concentrate was dried to prepare a dried broccoli sprout extract, and finally, the dried broccoli sprout was pulverized to prepare a powder filtered through about 60 mesh.
[제조예 2][Production Example 2]
제주용암해수로 키운 브로콜리 새싹 50㎏을 기계적으로 분쇄하여 브로콜리 새싹 분쇄물을 준비하였다.Broccoli sprouts were prepared by mechanically pulverizing 50 kg of broccoli sprouts grown with Jeju lava seawater.
[제조예 3] - 미로시나아제(myrosinase) 미처리[Preparation Example 3] - Myrosinase (myrosinase) untreated
제주용암해수로 키운 브로콜리 새싹 50㎏에 (주)비케이바이오사의 펄스전기장(PEF)을 이용하여 약 30분간 펄스에너지를 가해줌으로써 브로콜리 새싹의 세포를 파괴하였다. 그 후, 이와 같이 펄스에너지 처리로 세포가 파괴된 브로콜리 새싹을 대기 중에 방치시켜 브로콜리새싹에 함유된 미로시네이즈가 글루코라파닌과 반응하여 설포라판이 생성된 효소반응액을 추출하였다. 그 후, 이와 같이 추출된 브로콜리새싹 효소반응액을 약 3시간 동안 교반하였으며, 다음으로, 교반된 브로콜리새싹 효소반응액을 약 40℃의 온도에서 감압 농축시켜 브로콜리새싹 농축액을 준비하였다. 다음으로, 상기 브로콜리새싹 농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하였고, 마지막으로, 상기 브로콜리새싹 추출건조물을 분쇄하여 약 60메쉬로 여과된 분말을 제조하였다.The cells of broccoli sprouts were destroyed by applying pulse energy to 50 kg of broccoli sprouts grown in Jeju lava seawater for about 30 minutes using a pulse electric field (PEF) from BK Bio. Thereafter, the broccoli sprouts, whose cells were destroyed by the pulse energy treatment as described above, were left in the air, and myrosinase contained in the broccoli sprouts reacted with glucoraphanin to extract the enzyme reaction solution in which sulforaphane was produced. Then, the broccoli sprout enzyme reaction solution extracted in this way was stirred for about 3 hours, and then, the stirred broccoli sprout enzyme reaction solution was concentrated under reduced pressure at a temperature of about 40° C. to prepare a broccoli sprout concentrate. Next, the broccoli sprout concentrate was dried to prepare a dried broccoli sprout extract, and finally, the dried broccoli sprout extract was pulverized to prepare a powder filtered through about 60 mesh.
[제조예 4] - 브로콜리새싹 추출물 제조[Preparation Example 4] - Preparation of broccoli sprout extract
수돗물로 키운 브로콜리 새싹 50㎏에 (주)비케이바이오사의 펄스전기장(PEF)을 이용하여 약 1분간 펄스에너지를 가해줌으로써 브로콜리 새싹의 세포를 파괴하였다. 그 후, 이와 같이 펄스에너지 처리로 세포가 파괴된 브로콜리 새싹에 미로시나아제(myrosinase) 25g을 혼합하고 약 37℃의 온도로 약 2시간동안 반응시킨 후 브로콜리새싹을 발효주정으로 추출하였다. 그 후, 이와 같이 추출된 브로콜리새싹 발효주정 추출액을 약 3시간 동안 교반하였으며, 다음으로, 교반된 브로콜리새싹 발효주정 추출액을 약 40℃의 온도에서 감압 농축시켜 브로콜리새싹 추출농축액을 준비하였다. 다음으로, 상기 브로콜리새싹 추출농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하였고, 마지막으로, 상기 브로콜리새싹 건조물을 분쇄하여 약 60메쉬로 여과된 분말을 제조하였다.The cells of broccoli sprouts were destroyed by applying pulse energy to 50 kg of broccoli sprouts grown with tap water for about 1 minute using a pulse electric field (PEF) of BK Bio. Thereafter, 25 g of myrosinase was mixed with the broccoli sprouts whose cells were destroyed by the pulse energy treatment as described above and reacted at a temperature of about 37° C. for about 2 hours, and then the broccoli sprouts were extracted with fermented alcohol. Then, the broccoli sprout fermented alcohol extract thus extracted was stirred for about 3 hours, and then, the stirred broccoli sprout fermented alcohol extract was concentrated under reduced pressure at a temperature of about 40° C. to prepare a broccoli sprout extract concentrate. Next, the broccoli sprout extract concentrate was dried to prepare a broccoli sprout extract, and finally, the dried broccoli sprout was ground to prepare a powder filtered through about 60 mesh.
[제조예 5] - 브로콜리새싹 추출물 제조[Preparation Example 5] - Preparation of broccoli sprout extract
먹는샘물로 키운 브로콜리 새싹 50㎏에 (주)비케이바이오사의 펄스전기장(PEF)을 이용하여 약 1분간 펄스에너지를 가해줌으로써 브로콜리 새싹의 세포를 파괴하였다. 그 후, 이와 같이 펄스에너지 처리로 세포가 파괴된 브로콜리 새싹에 미로시나아제(myrosinase) 25g을 혼합하고 약 37℃의 온도로 약 2시간동안 반응시켜 브로콜리새싹 효소반응액을 발효주정으로 추출하였다. 그 후, 이와 같이 추출된 브로콜리새싹 발효주정 추출액을 약 3시간 동안 교반하였으며, 다음으로, 교반된 브로콜리새싹 발효주정 추출액을 약 40℃의 온도에서 감압 농축시켜 브로콜리새싹 농축액을 준비하였다. 다음으로, 상기 브로콜리새싹 농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하였고, 마지막으로, 상기 브로콜리새싹 추출건조물을 분쇄하여 약 60메쉬로 여과된 분말을 제조하였다.By applying pulse energy to 50 kg of broccoli sprouts grown in drinking spring water for about 1 minute using a pulse electric field (PEF) of BK Bio, the cells of broccoli sprouts were destroyed. Thereafter, 25 g of myrosinase was mixed with broccoli sprouts, whose cells were destroyed by the pulse energy treatment, and reacted at a temperature of about 37° C. for about 2 hours. The broccoli sprout enzyme reaction solution was extracted with fermented alcohol. Then, the broccoli sprout fermented alcohol extract thus extracted was stirred for about 3 hours, and then, the stirred broccoli sprout fermented alcohol extract was concentrated under reduced pressure at a temperature of about 40° C. to prepare a broccoli sprout concentrate. Next, the broccoli sprout concentrate was dried to prepare a dried broccoli sprout extract, and finally, the dried broccoli sprout extract was pulverized to prepare a powder filtered through about 60 mesh.
[제조예 6] - 브로콜리새싹 추출물 제조[Preparation Example 6] - Preparation of broccoli sprout extract
해양심층수로 키운 브로콜리 새싹 50㎏에 (주)비케이바이오사의 펄스전기장(PEF)을 이용하여 약 1분간 펄스에너지를 가해줌으로써 브로콜리 새싹의 세포를 파괴하였다. 그 후, 이와 같이 펄스에너지 처리로 세포가 파괴된 브로콜리 새싹에 미로시나아제(myrosinase) 25g을 혼합하고 약 37℃의 온도로 약 2시간동안 반응시켜 브로콜리새싹 효소반응액을 발효주정으로 추출하였다. 그 후, 이와 같이 추출된 브로콜리새싹 추출발효주정을 약 3시간 동안 교반하였으며, 다음으로, 교반된 브로콜리새싹 추출발효주정을 약 40℃의 온도에서 감압 농축시켜 브로콜리새싹 농축액을 준비하였다. 다음으로, 상기 브로콜리새싹 농축액을 건조시켜 브로콜리새싹 추출건조물을 준비하였고, 마지막으로, 상기 브로콜리새싹 추출건조물을 분쇄하여 약 60메쉬로 여과된 분말을 제조하였다.The cells of broccoli sprouts were destroyed by applying pulse energy to 50 kg of broccoli sprouts grown in deep sea water for about 1 minute using a pulse electric field (PEF) from BK Bio. Thereafter, 25 g of myrosinase was mixed with broccoli sprouts, whose cells were destroyed by the pulse energy treatment, and reacted at a temperature of about 37° C. for about 2 hours. The broccoli sprout enzyme reaction solution was extracted with fermented alcohol. Then, the broccoli sprout extract and fermented alcohol thus extracted was stirred for about 3 hours, and then, the stirred broccoli sprout extract and fermented alcohol was concentrated under reduced pressure at a temperature of about 40° C. to prepare a broccoli sprout concentrate. Next, the broccoli sprout concentrate was dried to prepare a dried broccoli sprout extract, and finally, the dried broccoli sprout extract was pulverized to prepare a powder filtered through about 60 mesh.
본 발명에서 사용되는 (주)비케이바이오사의 펄스전기장(PEF) 처리조건은 새싹이 담긴 액상 매질에 전기장 0.1 내지 15 kV/cm, 주파수 1 내지 120 Hz 및 에너지 1 내지 30 kJ로 0.1초 내지 200 초 동안 1 내지 100회 수행하는 것이 가능하다.Pulsed electric field (PEF) treatment conditions of BK Bio Co., Ltd. used in the present invention are 0.1 to 200 seconds with an electric field of 0.1 to 15 kV/cm, a frequency of 1 to 120 Hz, and an energy of 1 to 30 kJ in a liquid medium containing sprouts. It is possible to perform from 1 to 100 times during the period.
한편, 상기 제조예 1 내지 6에서 사용된 (주)비케이바이오사의 펄스전기장(PEF) 처리조건은 새싹이 담긴 액상 매질에 전기장 10 kV/cm, 주파수 80 Hz 및 에너지 15 kJ로 100초 동안 50회 수행하였다.On the other hand, the pulse electric field (PEF) treatment conditions of BK Bio Co., Ltd. used in Preparation Examples 1 to 6 were 50 times for 100 seconds with an electric field of 10 kV/cm, a frequency of 80 Hz, and an energy of 15 kJ in the liquid medium containing the sprouts. carried out.
[실시예 1][Example 1]
상기 제조예 1을 통하여 제조된 브로콜리새싹 추출물 5㎏을 부형제인 덱스트린과 고르게 혼합하여 본 발명에 따른 두뇌 건강기능개선제 조성물을 제조하였다.5 kg of the broccoli sprout extract prepared in Preparation Example 1 was evenly mixed with dextrin as an excipient to prepare a brain health function improving composition according to the present invention.
[비교예 1] - 브로콜리새싹 분쇄물[Comparative Example 1] - Broccoli sprout pulverized product
상기 제조예 2를 통하여 제조된 브로콜리새싹 분쇄물 5㎏을 부형제인 덱스트린과 고르게 혼합하여 혼합조성물을 제조하였다.5 kg of the ground broccoli sprout prepared in Preparation Example 2 was evenly mixed with dextrin as an excipient to prepare a mixed composition.
[비교예 2] - 브로콜리새싹즙[Comparative Example 2] - Broccoli sprout juice
상기 제조예 3을 통하여 제조된 조성물 5㎏을 부형제인 덱스트린과 고르게 혼합하여 혼합조성물을 제조하였다.5 kg of the composition prepared in Preparation Example 3 was evenly mixed with dextrin as an excipient to prepare a mixed composition.
[비교예 3] [Comparative Example 3]
상기 제조예 4를 통하여 제조된 브로콜리새싹 추출물 5㎏을 부형제인 덱스트린과 고르게 혼합하여 혼합조성물을 제조하였다.5 kg of the broccoli sprout extract prepared in Preparation Example 4 was evenly mixed with dextrin as an excipient to prepare a mixed composition.
[비교예 4] [Comparative Example 4]
상기 제조예 5를 통하여 제조된 브로콜리새싹 추출물 5㎏을 부형제인 덱스트린과 고르게 혼합하여 혼합조성물을 제조하였다.5 kg of the broccoli sprout extract prepared in Preparation Example 5 was evenly mixed with dextrin as an excipient to prepare a mixed composition.
[비교예 5] [Comparative Example 5]
상기 제조예 6을 통하여 제조된 브로콜리새싹 추출물 5㎏을 부형제인 덱스트린과 고르게 혼합하여 혼합조성물을 제조하였다.5 kg of the broccoli sprout extract prepared in Preparation Example 6 was evenly mixed with dextrin as an excipient to prepare a mixed composition.
상기 실시예 1을 통하여 제조된 두뇌 건강기능개선제 조성물을 이용하여 하기 실험을 수행하였다.The following experiment was performed using the brain health function improving agent composition prepared in Example 1.
[실험 1] - 신경세포 사멸억제효과 평가[Experiment 1] - Evaluation of neuronal cell death inhibitory effect
하기 (1) 내지 (3)의 실험방법을 통하여 신경세포 사멸억제효과를 평가하였다.The neuronal cell death inhibitory effect was evaluated through the following experimental methods (1) to (3).
(1) Western Blot Analysis: Caspase-3, Cleaved Caspase-3 단백질 발현 측정실험을 수행하였으며, 미처리 대조군에 비하여 Caspase-3, Cleaved Caspase-3 단백질 발현양이 각각 10배 증가하였음을 확인하였다.(1) Western Blot Analysis: Caspase-3 and Cleaved Caspase-3 protein expression measurement experiment was performed, and it was confirmed that the expression levels of Caspase-3 and Cleaved Caspase-3 proteins were each increased 10 times compared to the untreated control group.
(2) Western Blot Analysis: PARP, Cleaved PARP 단백질 발현 측정실험을 수행하였으며, 미처리 대조군에 비하여 PARP, Cleaved PARP 단백질 발현양이 각각 5배 증가하였음을 확인하였다.(2) Western Blot Analysis: An experiment was performed to measure the expression of PARP and cleaved PARP proteins, and it was confirmed that the expression levels of PARP and cleaved PARP proteins increased 5 times, respectively, compared to the untreated control group.
(3) Western Blot Analysis: Bax, Bcl-2 단백질 발현 측정실험을 수행하였으며, 미처리 대조군에 비하여 Bax, Bcl-2 단백질 발현양이 약 7배 증가하였음을 확인하였다.(3) Western Blot Analysis: An experiment was performed to measure the expression of Bax and Bcl-2 proteins, and it was confirmed that the expression of Bax and Bcl-2 proteins increased about 7 times compared to the untreated control group.
[실험 2] - 신경 세포 독성 유무[Experiment 2] - presence or absence of neurotoxicity
실시예 1의 조성물을 24, 48시간까지 처리한 결과 세포 독성이 관찰되지 않았다.As a result of treating the composition of Example 1 up to 24 and 48 hours, cytotoxicity was not observed.
[실험 3] - 세포생장률 실험[Experiment 3] - Cell growth rate test
실시예 1의 조성물을 48시간 처리 결과 1250 μg/mL에서 세포 생장률이 증가하는 경향을 확인하였다.As a result of treatment with the composition of Example 1 for 48 hours, it was confirmed that the cell growth rate increased at 1250 μg/mL.
상기 실험 1 내지 3을 통하여 실시예 1의 조성물에 의한 세포사멸 억제 관련 인자들의 단백질 발현 변화를 확인할 수 있었으며, 실시예 1의 조성물에 의하여 세포 독성이 나타나지 않는 10, 50 100 g/ml 농도에서 세포 사멸 억제 효과가 발휘됨을 확인하였다.Through the
[실험 4] - 신경염증 저해효과 평가[Experiment 4] - Evaluation of inhibitory effect on neuroinflammation
하기 (1) 내지 (3)의 실험을 통하여 신경염증 저해효과를 평가하였다.The neuroinflammation inhibitory effect was evaluated through the following experiments (1) to (3).
(1) Western Blot Analysis: NF-κB 단백질 발현 측정 및 세포핵으로의 이동을 관찰하였다.(1) Western Blot Analysis: NF-κB protein expression was measured and migration to the cell nucleus was observed.
(2) Western Blot Analysis: COX-2 단백질 발현이 증가함으로 관찰하였다.(2) Western Blot Analysis: It was observed that the expression of COX-2 protein increased.
(3) Western Blot Analysis: MAPKs (ERK, JNK, p38MAPK) 단백질 발현이 증가함을 관찰하였다.(3) Western Blot Analysis: MAPKs (ERK, JNK, p38MAPK) protein expression was observed to increase.
[실험 5] [Experiment 5]
실시예 1의 조성물을 처리함으로써 미처리 대조군에 비하여 세포 염증 반응으로 증가하는 NF-κB의 nuclear localization, COX-2 단백질 발현, MAPKs (ERK, p38 MAPK) 단백질의 인산화가 농도 의존적으로 감소함을 확인하였으며, 무 처리 군과 비교하였을 시 농도10, 50, 100 μg/mL에서 신경세포 염증반응 억제 효과를 p<0.05, p<0.01, p<0.001 수준에서 유의미한 차이를 가짐을 확인하였다.By treating the composition of Example 1, it was confirmed that the nuclear localization of NF-κB, COX-2 protein expression, and phosphorylation of MAPKs (ERK, p38 MAPK) proteins increased in a cell inflammatory response in a concentration-dependent manner compared to the untreated control group. , it was confirmed that there was a significant difference in the inhibitory effect of neuronal inflammatory response at concentrations of 10, 50, and 100 μg/mL at the levels of p<0.05, p<0.01, and p<0.001 when compared with the untreated group.
[실험 6] - 신경전달물질 및 시냅스가소성 회복평가[Experiment 6] - Neurotransmitter and synaptic plasticity recovery evaluation
실시예 1 조성물의 처리시 하기 (1) 내지 (3)의 실험을 통하여 신경전달물질 및 시냅스가소성 회복평가를 수행하였다.Example 1 During the treatment of the composition, neurotransmitters and synaptic plasticity recovery evaluation were performed through the experiments of (1) to (3) below.
(1) Acetylcholinesterase Assay: Acetylcholinesterase 활성이 증가함을 관찰하였다.(1) Acetylcholinesterase Assay: Acetylcholinesterase activity was observed to increase.
(2) ELISA (Enzyme-Linked Immunosorbent Assay): 세포에서 방출된 BDNF의 양이 증가함을 측정하였다.(2) ELISA (Enzyme-Linked Immunosorbent Assay): An increase in the amount of BDNF released from cells was measured.
(3) Western Blot Analysis: CREB, p-CREB 단백질 발현이 증가함을 관찰하였다.(3) Western Blot Analysis: It was observed that CREB and p-CREB protein expression increased.
[실험 7][Experiment 7]
실시예 1 조성물의 처리시 미처리 대조군에 비하여 Aβ 유도된 신경세포에서 Acetylcholinesterase의 활성을 억제시키고, 세포에서 방출된 BDNF (Brain-derived neurotrophic factor)의 양은 농도 의존적으로 증가시킴을 확인하였다.Example 1 It was confirmed that when the composition was treated, the activity of Acetylcholinesterase was inhibited in Aβ-induced neurons compared to the untreated control, and the amount of brain-derived neurotrophic factor (BDNF) released from the cells was increased in a concentration-dependent manner.
[실험 8][Experiment 8]
실시예 1 조성물의 처리시 미처리 대조군에 비하여 신경 전달 물질 관련 전사 인자인 CREB의 전사 활성이 농도 의존적으로 증가하였으며, 무 처리 군과 비교하였을 시, 농도10, 50, 100 μg/mL에서 시냅스 가소성이 회복되는 것을 p<0.05, p<0.01, p<0.001 수준에서 유의미한 차이를 가짐을 확인하였다.When the composition of Example 1 was treated, the transcriptional activity of CREB, a neurotransmitter-related transcription factor, was increased in a concentration-dependent manner as compared to the untreated control group. It was confirmed that there was a significant difference in the level of recovery at p <0.05, p <0.01, and p <0.001 levels.
[실험 9][Experiment 9]
실시예 1 조성물을 뚜렷한 치매 증상이 없는 75 노인 7명 (남자: 3명, 여자 4명)에게 30일간 1일 3회(회당 20㎖씩) 경구투여 하였으며, 실험참가자의 기억력에 미치는 영향을 평가하였다 (참가자 1 내지 3: 남자, 참가자 4 내지 7: 여자).Example 1 The composition of Example 1 was orally administered to 7 elderly people (male: 3, 4 female) without obvious symptoms of dementia 3 times a day (20 ml each) for 30 days, and the effect on the memory of the participants was evaluated. (
기억력 평가는 1 부터 20까지의 숫자가 적힌 숫자판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 숫자 암기력 평가 및 다양한 동물그림이 그려진 그림판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 그림 기억력 평가를 통하여 수행하였으며, 그 결과를 하기 표 1에 나타내었다 (숫자 암기력 평가점수/ 그림 암기력 평가점수) (5점 만점).For the memory evaluation, randomly show 10 of the number boards with numbers from 1 to 20, and show 10 randomly among the number memorization ability evaluation to evaluate how many of them can be remembered after 10 seconds, and the drawing board with various animal pictures. , was performed through picture memory evaluation to evaluate how many of them can be remembered after 10 seconds, and the results are shown in Table 1 below (numerical memorization power evaluation score/picture memorization power evaluation score) (out of 5 points).
(숫자 암기력 평가점수/그림 암기력 평가점수)(Number memorization skill evaluation score/figure memorization skill evaluation score)
상기 표 1의 결과를 살펴보면, 본 발명에 따른 조성물이 기억력 향상에 뚜렷하게 도움이 되는 것을 확인할 수 있다.Looking at the results in Table 1, it can be seen that the composition according to the present invention is clearly helpful in improving memory.
[실험 10][Experiment 10]
비교예 1 조성물을 뚜렷한 치매 증상이 없는 75 노인 7명 (남자: 3명, 여자 4명)에게 30일간 1일 3회(회당 20㎖씩) 경구투여 하였으며, 실험참가자의 기억력에 미치는 영향을 평가하였다 (참가자 1 내지 3: 남자, 참가자 4 내지 7: 여자).Comparative Example 1 The composition was orally administered to 7 elderly people (male: 3, 4 females) without obvious symptoms of dementia 3 times a day (20 ml each) for 30 days, and the effect on the memory of the participants was evaluated. (
기억력 평가는 1 부터 20까지의 숫자가 적힌 숫자판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 숫자 암기력 평가 및 다양한 동물그림이 그려진 그림판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 그림 기억력 평가를 통하여 수행하였으며, 그 결과를 하기 표 2에 나타내었다 (숫자 암기력 평가점수/ 그림 암기력 평가점수) (5점 만점).For memory evaluation, randomly show 10 of the number boards with numbers from 1 to 20, and
(숫자 암기력 평가점수/그림 암기력 평가점수)(Number memorization skill evaluation score/figure memorization skill evaluation score)
[실험 11][Experiment 11]
비교예 2 조성물을 뚜렷한 치매 증상이 없는 75 노인 7명 (남자: 3명, 여자 4명)에게 30일간 1일 3회(회당 20㎖씩) 경구투여 하였으며, 실험참가자의 기억력에 미치는 영향을 평가하였다 (참가자 1 내지 3: 남자, 참가자 4 내지 7: 여자).Comparative Example 2 The composition was orally administered to 7 elderly people (male: 3, 4 females) without obvious symptoms of dementia 3 times a day (20 ml each) for 30 days, and the effect on the memory of the participants was evaluated. (
기억력 평가는 1 부터 20까지의 숫자가 적힌 숫자판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 숫자 암기력 평가 및 다양한 동물그림이 그려진 그림판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 그림 기억력 평가를 통하여 수행하였으며, 그 결과를 하기 표 3에 나타내었다 (숫자 암기력 평가점수/ 그림 암기력 평가점수) (5점 만점).For the memory evaluation, randomly show 10 of the number boards with numbers from 1 to 20, and show 10 randomly among the number memorization ability evaluation to evaluate how many of them can be remembered after 10 seconds, and the drawing board with various animal pictures. , was performed through picture memory evaluation to evaluate how many of them can be remembered after 10 seconds, and the results are shown in Table 3 below (numerical memorization power evaluation score/picture memorization power evaluation score) (out of 5 points).
(숫자 암기력 평가점수/그림 암기력 평가점수)(Number memorization skill evaluation score/figure memorization skill evaluation score)
[실험 12][Experiment 12]
비교예 3 조성물을 뚜렷한 치매 증상이 없는 75 노인 7명 (남자: 3명, 여자 4명)에게 30일간 1일 3회(회당 20㎖씩) 경구투여 하였으며, 실험참가자의 기억력에 미치는 영향을 평가하였다 (참가자 1 내지 3: 남자, 참가자 4 내지 7: 여자).Comparative Example 3 The composition was orally administered to 7 elderly people (male: 3, 4 females) without obvious symptoms of dementia 3 times a day (20 ml each) for 30 days, and the effect on the memory of the participants was evaluated. (
기억력 평가는 1 부터 20까지의 숫자가 적힌 숫자판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 숫자 암기력 평가 및 다양한 동물그림이 그려진 그림판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 그림 기억력 평가를 통하여 수행하였으며, 그 결과를 하기 표 4에 나타내었다 (숫자 암기력 평가점수/ 그림 암기력 평가점수) (5점 만점).For the memory evaluation, randomly show 10 of the number boards with numbers from 1 to 20, and show 10 randomly among the number memorization ability evaluation to evaluate how many of them can be remembered after 10 seconds, and the drawing board with various animal pictures. , was performed through picture memory evaluation, which evaluates how many of them can be remembered after 10 seconds, and the results are shown in Table 4 below (numerical memorization power evaluation score/picture memorization power evaluation score) (out of 5 points).
(숫자 암기력 평가점수/그림 암기력 평가점수)(Number memorization skill evaluation score/figure memorization skill evaluation score)
[실험 13][Experiment 13]
비교예 4 조성물을 뚜렷한 치매 증상이 없는 75 노인 7명 (남자: 3명, 여자 4명)에게 30일간 1일 3회(회당 20㎖씩) 경구투여 하였으며, 실험참가자의 기억력에 미치는 영향을 평가하였다 (참가자 1 내지 3: 남자, 참가자 4 내지 7: 여자).Comparative Example 4 The composition was orally administered to 7 elderly people (male: 3, 4 female) without obvious symptoms of dementia 3 times a day (20 ml each) for 30 days, and the effect on the memory of the participants was evaluated. (
기억력 평가는 1 부터 20까지의 숫자가 적힌 숫자판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 숫자 암기력 평가 및 다양한 동물그림이 그려진 그림판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 그림 기억력 평가를 통하여 수행하였으며, 그 결과를 하기 표 5에 나타내었다 (숫자 암기력 평가점수/ 그림 암기력 평가점수) (5점 만점).For the memory evaluation, randomly show 10 of the number boards with numbers from 1 to 20, and show 10 randomly among the number memorization ability evaluation to evaluate how many of them can be remembered after 10 seconds, and the drawing board with various animal pictures. , was performed through picture memory evaluation to evaluate how many of them can be remembered after 10 seconds, and the results are shown in Table 5 below (numerical memorization power evaluation score/picture memorization power evaluation score) (out of 5 points).
(숫자 암기력 평가점수/그림 암기력 평가점수)(Number memorization score/figure memorization score)
[실험 14][Experiment 14]
비교예 5 조성물을 뚜렷한 치매 증상이 없는 75 노인 7명 (남자: 3명, 여자 4명)에게 30일간 1일 3회(회당 20㎖씩) 경구투여 하였으며, 실험참가자의 기억력에 미치는 영향을 평가하였다 (참가자 1 내지 3: 남자, 참가자 4 내지 7: 여자).The composition of Comparative Example 5 was orally administered to 7 elderly people (male: 3, 4 female) without obvious symptoms of dementia 3 times a day (20 ml each) for 30 days, and the effect on the memory of the participants was evaluated. (
기억력 평가는 1 부터 20까지의 숫자가 적힌 숫자판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 숫자 암기력 평가 및 다양한 동물그림이 그려진 그림판 중 무작위로 10개를 보여주고, 10초 후에 이들 중 몇개를 기억해내는지 평가하는 그림 기억력 평가를 통하여 수행하였으며, 그 결과를 하기 표 6에 나타내었다 (숫자 암기력 평가점수/ 그림 암기력 평가점수) (5점 만점).For the memory evaluation, randomly show 10 of the number boards with numbers from 1 to 20, and show 10 randomly among the number memorization ability evaluation to evaluate how many of them can be remembered after 10 seconds, and the drawing board with various animal pictures. , was performed through picture memory evaluation to evaluate how many of them can be remembered after 10 seconds, and the results are shown in Table 6 below (numerical memorization power evaluation score/picture memorization power evaluation score) (out of 5 points).
(숫자 암기력 평가점수/그림 암기력 평가점수)(Number memorization skill evaluation score/figure memorization skill evaluation score)
Claims (6)
상기 브로콜리새싹 추출물은
브로콜리 새싹에 펄스에너지를 가하여 처리하는 단계(S100);
펄스에너지 처리된 상기 브로콜리 새싹을 착즙하여 새싹착즙액을 준비하는 단계(S200);
상기 새싹착즙액에 미로시나아제(myrosinase)를 혼합하고 반응시킨 후 발효주정으로 추출하여 새싹 발효주정 추출액을 준비하는 단계(S300);
상기 새싹 발효주정 추출액을 교반하고, 교반된 브로콜리 새싹 발효주정 추출액을 감압 농축시켜 브로콜리새싹 농축액을 준비하는 단계(S400);
상기 브로콜리 새싹 농축액을 건조시켜 브로콜리 새싹 추출건조물을 준비하는 단계(S500); 및
상기 브로콜리 새싹 추출건조물을 분쇄하여 분말로 만드는 단계(S600);를 통하여 제조되는 것인 두뇌건강기능 개선제 조성물.The method according to claim 1,
The broccoli sprout extract is
Processing by applying pulse energy to broccoli sprouts (S100);
Preparing a sprout juice by squeezing the broccoli sprouts treated with pulse energy (S200);
Preparing a sprout fermented alcohol extract by mixing and reacting myrosinase with the sprout juice and extracting it with fermented alcohol (S300);
preparing a broccoli sprout concentrate by stirring the sprout fermented alcohol extract and concentrating the stirred broccoli sprout fermented alcohol extract under reduced pressure (S400);
Preparing the broccoli sprout extract by drying the broccoli sprout concentrate (S500); and
Brain health function improving agent composition which is prepared through; grinding the dried broccoli sprout extract into a powder (S600).
상기 조성물은 기억력 개선제인 것을 특징으로 하는 두뇌건강기능 개선제 조성물.The method according to claim 1 or 2,
The composition is a brain health function improving agent composition, characterized in that the memory improver.
상기 조성물은 신경세포 사멸 억제제인 것을 특징으로 하는 두뇌건강기능 개선제 조성물.The method according to claim 1 or 2,
The composition is a brain health function improving agent composition, characterized in that the nerve cell death inhibitor.
상기 조성물은 신경염증 저해제인 것을 특징으로 하는 두뇌건강기능 개선제 조성물.The method according to claim 1 or 2,
The composition is a brain health function improving composition, characterized in that the neuroinflammation inhibitor.
상기 조성물은 신경전달물질 및 시냅스 가소성 회복제인 것을 특징으로 하는 두뇌건강기능 개선제 조성물.The method according to claim 1 or 2,
The composition is a brain health function improving composition, characterized in that the neurotransmitter and synaptic plasticity recovery agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200135155A KR20220051579A (en) | 2020-10-19 | 2020-10-19 | Brain health improving formulation containing Pulsed Electric Field treated broccoli sprout extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200135155A KR20220051579A (en) | 2020-10-19 | 2020-10-19 | Brain health improving formulation containing Pulsed Electric Field treated broccoli sprout extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220051579A true KR20220051579A (en) | 2022-04-26 |
Family
ID=81391406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200135155A KR20220051579A (en) | 2020-10-19 | 2020-10-19 | Brain health improving formulation containing Pulsed Electric Field treated broccoli sprout extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220051579A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102494695B1 (en) | 2022-11-29 | 2023-01-31 | 하현주 | Method for manufacturing health functional food containing broccoli stems |
KR102556210B1 (en) | 2022-11-29 | 2023-07-19 | 하현주 | Method for manufacturing health functional food containing broccoli stems |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150121788A (en) | 2014-04-21 | 2015-10-30 | 조정희 | Composition comprising CitriPericarpium having the protection of neuronal cells and the improvement of memory and cognition ability, and functional foodproduct containing the same |
-
2020
- 2020-10-19 KR KR1020200135155A patent/KR20220051579A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150121788A (en) | 2014-04-21 | 2015-10-30 | 조정희 | Composition comprising CitriPericarpium having the protection of neuronal cells and the improvement of memory and cognition ability, and functional foodproduct containing the same |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102494695B1 (en) | 2022-11-29 | 2023-01-31 | 하현주 | Method for manufacturing health functional food containing broccoli stems |
KR102556210B1 (en) | 2022-11-29 | 2023-07-19 | 하현주 | Method for manufacturing health functional food containing broccoli stems |
KR20230112582A (en) | 2022-11-29 | 2023-07-27 | 하현주 | Method for manufacturing health functional food containing broccoli stems |
KR20230112583A (en) | 2022-11-29 | 2023-07-27 | 하현주 | Method for manufacturing health functional food containing broccoli stems |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20220051579A (en) | Brain health improving formulation containing Pulsed Electric Field treated broccoli sprout extract | |
Guo et al. | Antioxidant and antiproliferative activities of purslane seed oil | |
Islam et al. | Antioxidant and hepatoprotective activity of an ethanol extract of Syzygium jambos (L.) leaves | |
Tufts et al. | Antioxidant and anti-inflammatory activities of Kenyan leafy green vegetables, wild fruits, and medicinal plants with potential relevance for kwashiorkor | |
JP2007045713A (en) | Extract of spore of ganoderma lucidum and preparation of spore of ganoderma lucidum | |
CN113543793A (en) | Preparation method of spirulina extract, and pharmaceutical composition and health functional food containing spirulina extract for improving cognitive ability | |
Chaves et al. | Palmatine antioxidant and anti-acetylcholinesterase activities: A pre-clinical assessment | |
Chen et al. | Effect of extraction methods on the active compounds and antioxidant properties of ethanolic extracts of Echinacea purpurea flower | |
Hayes et al. | The absence of genotoxicity of a mixture of aloin A and B and a commercial aloe gel beverage | |
Mbah et al. | Ethanolic extract of Solanum melongena Linn fruit mitigated monosodium glutamate-induced oxidative stress | |
Abu et al. | Renal Oxidative Status in Diabetic Wistar Rats Administered Methanol Fraction of Ethanol Extract of Dialium guineense Stem Bark | |
KR101838523B1 (en) | Pill using aronia berry and manufacturing method thereof | |
KR20190101063A (en) | Composition containing natural material extract for preventing and improving respiratory organ disease | |
KR102155187B1 (en) | Composition for functional food having atopic dermatitis treatment property and antioxidant property and method for manufacturing the same | |
KR101070382B1 (en) | Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it | |
Kmail et al. | Modulatory Effects of Leave and Fruit Extracts of Ficus sycomorus on Cytostatic and Inflammatory Mediators in Monocultures and Co-cultures of Human Keratinocyte (HaCat) and Human Monocyte (THP-1) Cell Lines | |
KR102121048B1 (en) | Antioxidant and anti-inflammatory composition comprising mixed extracts of ecklonia cava extract and scoria | |
CN102847142A (en) | Oral biological medicine used for treating chemotherapy and radiotherapy syndromes, and preparation method thereof | |
TWI692362B (en) | Use of extraction of emblica officinalis in preparing pharmaceutical composition for improving activity mitochondriain liver | |
KR101342570B1 (en) | Functional foods containing red ginseng and walnut | |
KR20210065417A (en) | A composition comprising quercetin 3-O-a-L-arabinofuranoside or 2-oxopomolic acid for preventing or treating neurodegenerative disease | |
KR20200082734A (en) | A composition comprising alverine for preventing or treating for inflammatory disease | |
KR101621147B1 (en) | Polygala tenuifolia and Acorus Gramineus Extracts For Cognitive Function Activity Effect And Manufacturing Method of thereof | |
KR20220103362A (en) | Pharmaceutical composition for preventing or treating an inflammatory disease comprising an extract of Portulaca oleracea | |
KR101500076B1 (en) | Bacalein and Acorus Gramineus Extracts For Cognitive Function Activity Effect And Manufacturing Method of thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |